bit.bio discovery GmbH

Description

bit.bio discovery GmbH operates an experimental platform that combines human induced pluripotent stem cells (iPSCs) with CRISPR-based perturbations to generate and screen cellular models for early-stage and preclinical drug discovery.

bit.bio discovery GmbH is located in the Vienna ecosystem.

Related

• Roslin TechnologiesRoslin Technologies develops pluripotent animal stem cell lines (iPSCs and ESCs) and supplies cell types for cultivated meat customers,…
• Heartbeat BioHeartbeat Bio builds customizable Cardioid heart chamber models from iPSCs and provides assay platforms and disease-specific models for…
• OrganoTherapeuticsOrganoTherapeutics creates human iPSC-derived midbrain organoids, assembloids, and patient-specific Parkinson’s cell models, then provides…
• Immitra BioImmitra Bio develops an in‑vivo gene editing and stem cell therapy platform aimed at producing single, off‑the‑shelf injections to treat…
• SarcuraSarcura develops a miniaturized, autonomous device platform for cell therapy manufacturing, using control intelligence, semiconductor chip…
• InSpheroInSphero provides human-tissue 3D in vitro cell-culture models, spheroid and organoid tools, and automation-compatible plates that support…
• ORF GeneticsORF Genetics produces animal-free, plant-made recombinant growth factors and cytokines used to support human cell cultures, skincare…
• Aukera Therapeutics GmbHAukera Therapeutics GmbH develops the first RAPTOR inhibitors, using an AI-driven drug discovery platform and mTOR biology expertise to…
• SNIPR BIOMESNIPR BIOME develops CRISPR-based medicines that use bacteriophages, engineered probiotics, and CRISPR systems to target…